Takuya Fujimaru
11PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 24, 2026
Changes in mean corpuscular volume after erythropoiesis-stimulating agent treatment are associated with renal outcomes in non-dialysis-dependent chronic kidney disease.Raku Son, Takuya Fujimaru, Tatsuo Kagimura
|Jul 24, 2025
Management of hyperkalemia: strategic clinical actions in real-world practice.Takuya Fujimaru, Kazuhito Hirose, Masahiko Yazawa
|Jun 11, 2025
Pathophysiology and causes of hyperkalemia: unraveling causes beyond kidney dysfunction.Takuya Fujimaru, Kazuhito Hirose, Masahiko Yazawa
|May 04, 2025
Risk factors for unexpected clinical deterioration in hospitalized patients undergoing maintenance hemodialysis.Nozomi Kadota, Takuya Fujimaru, Osamu Takahashi
|Oct 17, 2024
Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.Daishi Hirano, Takuya Fujimaru, Mayumi Sako
|Jun 24, 2024
Barriers to conservative kidney management for Japanese healthcare professionals involved in the treatment of end-stage renal disease.Yumi Sota, Takuya Fujimaru, Kyoko Kobayashi
Pageof 2
